Skip to main content
PLRZ
NASDAQ Industrial Applications And Services

Polyrizon Closes $4.0M Registered Direct Offering and Private Placement

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$10.812
Mkt Cap
$23.424M
52W Low
$2.88
52W High
$18.2
52W Position info
275% above low
Off High info
41% below high
Rel. Volume info
2.3× avg
Market data snapshot near publication time

PLRZ has more than doubled off its 52-week low of $2.88 on elevated volume (2.3× avg).

Summary

Polyrizon closed a $4.0 million registered direct offering and private placement, issuing shares and warrants to a single institutional investor at $12.00 per unit.


Key Events · Financing and Capital Events · PLRZ

  • $4.0M Offering Closed

    Polyrizon closed a registered direct offering and concurrent private placement with a single institutional investor, raising approximately $4.0 million in gross proceeds.

  • Securities Issued

    The company issued 232,500 ordinary shares, 30,000 pre-funded warrants, 70,833 PIPE pre-funded warrants, and 333,333 common warrants at a combined offering price of $12.00 per unit.

  • Warrant Terms

    Common warrants have an exercise price of $12.00 per share, above the current stock price of $10.81, creating potential future dilution if the stock appreciates above that level.

  • Use of Proceeds

    Net proceeds will be used for general corporate purposes and working capital, supporting the company's NASARIX clinical development program.


Analysis · PLRZ · Industrial Applications And Services

Polyrizon raised $4.0 million in gross proceeds through a registered direct offering and concurrent private placement with a single institutional investor. The deal includes 232,500 ordinary shares, 30,000 pre-funded warrants, 70,833 PIPE pre-funded warrants, and 333,333 common warrants at $12.00 per unit. The common warrants carry a $12.00 exercise price, which is above the current stock price of $10.81, meaning they are out-of-the-money at today's price. The capital extends the company's runway for its NASARIX clinical development program, but the warrant overhang creates potential future dilution if the stock appreciates.

How filings like this one have moved

In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PLRZ was trading at $10.81 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $23.4M. The 52-week trading range was $2.88 to $18.20. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PLRZ - Latest Insights

PLRZ
Sep 04, 2026, 9:19 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $11.01
Real-time Price: $10.49 info
Change: -$0.520 (-5%) info
Market Cap: $25.5M info
PLRZ
Sep 04, 2026, 9:16 AM EDT
Filing Type: 424B5
Importance Score:
7
Price at Filing: $11.01
Real-time Price: $10.49 info
Change: -$0.520 (-5%) info
Market Cap: $25.5M info
PLRZ
Sep 03, 2026, 8:50 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $12.01
Real-time Price: $10.49 info
Change: -$1.52 (-13%) info
Market Cap: $25.5M info
PLRZ
Sep 02, 2026, 7:32 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $14.22
Real-time Price: $10.49 info
Change: -$3.73 (-26%) info
Market Cap: $25.5M info
PLRZ
Aug 20, 2026, 4:00 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $10.96
Real-time Price: $10.49 info
Change: -$0.470 (-4%) info
Market Cap: $25.5M info